Related Experiment Videos
Consensus statement on chronic and subacute high altitude diseases
Fabiola León-Velarde1, Marco Maggiorini, John T Reeves
1Cayetano Heredia University/IIA, Department of Biological and Physiological Sciences, Oxygen Transport Laboratory, Lima 100, Perú. fabiolv@upch.rfu.pe
Insights
This consensus statement provides guidance on chronic and subacute high altitude diseases. Early identification and intervention by on-site personnel can prevent most high altitude illnesses.
Area of Science:
- High-altitude medicine and physiology
- International consensus on chronic and subacute high altitude diseases
Background:
- This statement addresses common chronic and subacute high altitude diseases.
- It is based on published, peer-reviewed literature and expert interpretation.
- The International Society for Mountain Medicine (ISMM) developed this consensus.
Framework:
- Provides criteria for diagnosing and managing high altitude diseases.
- Acknowledges geographic variations in disease development.
- Aims to align health policies with current knowledge.
Implementation:
- Informs on-site medical services for high altitude health problem resolution.
- Defines, diagnoses, treats, and prevents common chronic high altitude diseases.
- Emphasizes the importance of on-site personnel in disease management.
Implications:
- Highlights that most high altitude diseases are preventable.
- Stresses the need for current state-of-the-art knowledge in health policies.
- Facilitates appropriate care for individuals living or working at high altitudes.
Abstract:
This is an international consensus statement of an ad hoc committee formed by the International Society for Mountain Medicine (ISMM) at the VI World Congress on Mountain Medicine and High Altitude Physiology (Xining, China; 2004) and represents the committee's interpretation of the current knowledge with regard to the most common chronic and subacute high altitude diseases. It has been developed by medical and scientific authorities from the committee experienced in the recognition and prevention of high altitude diseases and is based mainly on published, peer-reviewed articles. It is intended to include all legitimate criteria for choosing to use a specific method or procedure to diagnose or manage high altitude diseases. However, the ISMM recognizes that specific patient care decisions depend on the different geographic circumstances involved in the development of each chronic high altitude disease. These guidelines are established to inform the medical services on site who are directed to solve high altitude health problems about the definition, diagnosis, treatment, and prevention of the most common chronic high altitude diseases. The health problems associated with life at high altitude are well documented, but health policies and procedures often do not reflect current state-of-the-art knowledge. Most of the cases of high altitude diseases are preventable if on-site personnel identify the condition and implement appropriate care.
Related Concept Videos
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: